Covered recipient · General Payments record
JILL L DUFFY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2023
$383.85
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $262.45 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $130.29 | 11 |
| Averitas Pharma Inc. | $49.44 | 3 |
| Abbott Laboratories | $23.67 | 1 |
| PFIZER INC. | $21.92 | 1 |
| Collegium Pharmaceutical, Inc. | $18.96 | 1 |
| Lilly USA, LLC | $18.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.67 | 10/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018422697 | CMS |
| ABBVIE INC. | $3.97 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814223 | CMS |
| ABBVIE INC. | $3.94 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814231 | CMS |
| ABBVIE INC. | $19.53 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814239 | CMS |
| ABBVIE INC. | $6.10 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814247 | CMS |
| ABBVIE INC. | $16.21 | 08/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814255 | CMS |
| ABBVIE INC. | $16.90 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814263 | CMS |
| ABBVIE INC. | $10.65 | 10/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814273 | CMS |
| ABBVIE INC. | $19.99 | 10/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814281 | CMS |
| ABBVIE INC. | $10.91 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814289 | CMS |
| ABBVIE INC. | $7.09 | 11/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814297 | CMS |
| ABBVIE INC. | $15.00 | 11/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003814305 | CMS |
| Averitas Pharma Inc. | $19.70 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054270131 | CMS |
| Averitas Pharma Inc. | $14.87 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054270139 | CMS |
| Averitas Pharma Inc. | $14.87 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054270143 | CMS |
| Collegium Pharmaceutical, Inc. | $18.96 | 06/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987394295 | CMS |
| Lilly USA, LLC | $18.17 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032959459 | CMS |
| PFIZER INC. | $21.92 | 10/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050265877 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.